|
|
|
|
|
 |
| |
David E. Fisher , MD, PhD
Chairman, Department of Dermatology
Director, Melanoma Program in Medical Oncology
Massachusetts General Hospital
Professor, Pediatric Hematology/Oncology
Harvard Medical School
website: :http: //research.dfci.harvard.edu/fisherlab/
|
|
|
|
|
| |
Topic:
|
|
"Transcriptional and signaling pathways
in melanoma" |
|
| |
|
|
|
|
| |
When:
|
|
Monday, March 23, 2009
12:00PM – 1:00PM
|
|
| |
Location:
|
|
BALDWIN AUDITORIUM, LURIE BUILDING |
|
| |
Hosted by the students of the Carcinogenesis Training Program |
|
| |
Selected Recent References David E. Fisher, MD, PhD
Robinson KC, Fisher DE. Specification and loss of melanocyte stem cells. Semin Cell Dev Biol. 2009 Feb;20(1):111-6. Epub 2008 Dec 13.
Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE. Chromatin structure analyses identify miRNA promoters .Genes Dev. 2008 Nov 15;22(22):3172-83.
Jiang X, Zhou J, Yuen NK, Corless CL, Heinrich MC, Fletcher JA, Demetri GD, Widlund HR, Fisher DE, Hodi FS. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin Cancer Res. 2008 Dec 1;14(23):7726-32.
Osawa M, Fisher DE. Notch and melanocytes: diverse outcomes from a single signal. J Invest Dermatol. 2008 Nov;128(11):2571-4.
Hodi FS, Fisher DE. Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma. Nat Clin Pract Oncol. 2008 Dec;5(12):696-7. Epub 2008 Oct 14.
 View more Publications by David E. Fisher, MD, PhD;
listed in the National Library of Medicine (PubMed) |
|
|
|
|
|
|
